» Articles » PMID: 33532709

Mutational Signatures and Heterogeneous Host Response Revealed Via Large-scale Characterization of SARS-CoV-2 Genomic Diversity

Overview
Journal iScience
Publisher Cell Press
Date 2021 Feb 3
PMID 33532709
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

To dissect the mechanisms underlying the inflation of variants in the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) genome, we present a large-scale analysis of intra-host genomic diversity, which reveals that most samples exhibit heterogeneous genomic architectures, due to the interplay between host-related mutational processes and transmission dynamics. The decomposition of minor variants profiles unveils three non-overlapping mutational signatures related to nucleotide substitutions and likely ruled by APOlipoprotein B Editing Complex (APOBEC), Reactive Oxygen Species (ROS), and Adenosine Deaminase Acting on RNA (ADAR), highlighting heterogeneous host responses to SARS-CoV-2 infections. A corrected-for-signatures analysis demonstrates that such mutational processes are affected by purifying selection, with important exceptions. In fact, several mutations appear to transit toward clonality, defining new clonal genotypes that increase the overall genomic diversity. Furthermore, the phylogenomic analysis shows the presence of homoplasies and supports the hypothesis of transmission of minor variants. This study paves the way for the integrated analysis of intra-host genomic diversity and clinical outcomes of SARS-CoV-2 infections.

Citing Articles

An Expanding Universe of Mutational Signatures and Its Rapid Evolution in Single-Stranded RNA Viruses.

Yang Y, Zhang X, Chen T, Wu F, Huang Y, Qu Y Mol Biol Evol. 2025; 42(2).

PMID: 39823310 PMC: 11796089. DOI: 10.1093/molbev/msaf009.


C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic.

Simmonds P mBio. 2024; 15(12):e0249324.

PMID: 39475243 PMC: 11633203. DOI: 10.1128/mbio.02493-24.


SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infection.

Goldswain H, Penrice-Randal R, Donovan-Banfield I, Duffy C, Dong X, Randle N Genome Med. 2024; 16(1):89.

PMID: 39014481 PMC: 11251137. DOI: 10.1186/s13073-024-01360-1.


Mutational Patterns Observed in SARS-CoV-2 Genomes Sampled From Successive Epochs Delimited by Major Public Health Events in Ontario, Canada: Genomic Surveillance Study.

Chen D, Randhawa G, Soltysiak M, de Souza C, Kari L, Singh S JMIR Bioinform Biotechnol. 2024; 3(1):e42243.

PMID: 38935965 PMC: 11135226. DOI: 10.2196/42243.


Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia: A Retrospective Genomic Surveillance Study.

Shempela D, Chambaro H, Sikalima J, Cham F, Njuguna M, Morrison L Int J Mol Sci. 2024; 25(12).

PMID: 38928045 PMC: 11203853. DOI: 10.3390/ijms25126338.


References
1.
Seemann T, Lane C, Sherry N, Duchene S, Goncalves da Silva A, Caly L . Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020; 11(1):4376. PMC: 7462846. DOI: 10.1038/s41467-020-18314-x. View

2.
Bandelt H, Quintana-Murci L, Salas A, Macaulay V . The fingerprint of phantom mutations in mitochondrial DNA data. Am J Hum Genet. 2002; 71(5):1150-60. PMC: 385090. DOI: 10.1086/344397. View

3.
Koyama T, Platt D, Parida L . Variant analysis of SARS-CoV-2 genomes. Bull World Health Organ. 2020; 98(7):495-504. PMC: 7375210. DOI: 10.2471/BLT.20.253591. View

4.
Daniloski Z, Jordan T, Ilmain J, Guo X, Bhabha G, tenOever B . The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types. Elife. 2021; 10. PMC: 7891930. DOI: 10.7554/eLife.65365. View

5.
Gutierrez S, Yvon M, Pirolles E, Garzo E, Fereres A, Michalakis Y . Circulating virus load determines the size of bottlenecks in viral populations progressing within a host. PLoS Pathog. 2012; 8(11):e1003009. PMC: 3486874. DOI: 10.1371/journal.ppat.1003009. View